Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • ID: 4471483
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Dec 31st 2018
1 of 4

FEATURED COMPANIES

  • AB Sciences
  • Astrazeneca Plc
  • Boston Biomedical
  • Genticel S.A.
  • Inovio Pharmaceuticals
  • Novartis Ag
  • MORE
Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. More than 400,000 incidences of oropharyngeal cancer are reported every year globally. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor driving the market growth. Moreover, growing number of smokers and alcohol consumers which are most prone to this cancer has been a major factor for the market growth. Around 1.1 billion people smoked tobacco in 2015 and more than 2 billion people consumed alcoholic drinks globally. Such high number reflects a high chance of oropharyngeal cancer in the consumers.

High costs of oropharyngeal cancer treatment along with low awareness towards this cancer act as major restraints for the market growth. However, ongoing improvements in the healthcare expenditure from government and availability of reimbursements is factor augmenting the market growth. Additionally, rising number of minimally invasive surgeries for treatment of the cancer is expected to drive the future market growth. At present, Transoral laser microsurgery and Transoral robotic surgery are widely adopted minimally invasive surgeries for treatment of oropharyngeal cancer.

On the basis of the geography, oropharyngeal cancer market is segmented into North America, Asia Pacific, Europe and Rest of the World. North America has been predicted to dominate the global oropharyngeal cancer market due to well established health infrastructure and high prevalence of this cancer towards people. Additionally, APAC will be the fastest growing region during the fastest growing period due to rising geriatric population and increasing incidence and prevalence rate of oropharyngeal cancer.

The Key Players in the Oropharyngeal cancer market are Merck & Co., GE Healthcare, Synta Pharmaceuticals Corp, VLPbio, Novartis AG, Immunovaccines, Inc., Inovio Pharmaceuticals and others. These players adopt various strategies such as partnership, R&D, M&A, product launch and joint ventures to create for more market opportunities. Inovio Pharmaceuticals has a clinical collaboration with the Parker Institute for Cancer Immunotherapy in January, 2018 to design innovative studies having the potential to address cancers with high unmet need.

Global Oropharyngeal cancer market can be segmented on the basis of diagnosis type, treatment type and end-users. On the basis of diagnosis type, the market can be further segmented into endoscopy, biopsy and imaging (MRI Scan, CT-Scan, PET-CT Scan). The market has been segmented on the basis of treatment type into surgery, chemotherapy, radiation therapy, targeted therapy and others. Moreover, the market has been segmented on the basis of end-users into hospitals, ambulatory surgery centers and others.

The Report Covers:
  • Comprehensive research methodology of Global Oropharyngeal Cancer Market.
  • This report also includes detailed and extensive market overview with current market recommendations & key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Oropharyngeal Cancer Market.
  • Insights about market determinants which are stimulating the Global Oropharyngeal Cancer Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AB Sciences
  • Astrazeneca Plc
  • Boston Biomedical
  • Genticel S.A.
  • Inovio Pharmaceuticals
  • Novartis Ag
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders
1.2.4. Exceptions

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion

3. Market Determinant
3.1. Motivators
3.1.1. Rising Prevalence of Oropharyngeal Cancer
3.1.2. Availability of Several Reimbursement Policies
3.1.3. Increasing Consumption of Tobacco and Other Products
3.1.4. Escalating Number of Human Papillomavirus (Hpv) Infection
3.1.5. Rising Geraitric Population and Oropharynegal Incidences Associated With Them
3.2. Restraints
3.2.1. High Cost of Treatment
3.2.2. Less Awareness Concerning Oropharyngeal Cancer and Its Treatment in Developing Countries
3.3. Opportunity
3.3.1. Emerging Demand in APAC Region Due to Rising Incidences
3.3.2. Growing Number of Minimal INVasive Surgeries

4. Market Segmentation
4.1. by Diagnosis Type
4.1.1. Endoscopy
4.1.2. Biopsy
4.1.3. Imaging
4.1.4. Mri Scan
4.1.5. CT Scan
4.1.6. Pet-Ct Scan
4.2. by Treatment Type
4.2.1. Surgery
4.2.2. Chemotherapy
4.2.3. Radiation Therapy
4.2.4. Targeted Therapy
4.2.5. Others
4.3. by End-Users
4.3.1. Hospitals
4.3.2. Ambulatory Surgery Centres
4.3.3. Others

5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.1.3. Rest of North America
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Ab Sciences
7.2. Advaxis Inc.
7.3. Astrazeneca PLC
7.4. Bayer Ag
7.5. Boston Biomedical
7.6. Bristol-Myers Squibb Company
7.7. GE Healthcare
7.8. Genticel S.A.
7.9. Immunovaccine, Inc.
7.10. Inovio Pharmaceuticals
7.11. Kolltan Pharmaceuticals Inc.
7.12. Merck & Co. Inc.
7.13. Novartis Ag
7.14. Pnp Therapeutics Inc.
7.15. Synta Pharmaceuticals Corp
7.16. Vlpbio

List of Tables:
Table 1 Global Oropharyngeal Cancer Market Research and Analysis by Diagnosis Type, 2017-2023 ($ Million)
Table 2 Global Oropharyngeal Cancer Endoscopy Market Research and Analysis, 2017-2023 ($ Million)
Table 3 Global Oropharyngeal Cancer Biopsy Market Research and Analysis, 2017-2023 ($ Million)
Table 4 Global Oropharyngeal Cancer Imaging Diagnosis Market Research and Analysis, 2017-2023 ($ Million)
Table 5 Global Oropharyngeal Cancer Mri Scan Market Research and Analysis, 2017-2023 ($ Million)
Table 6 Global Oropharyngeal Cancer Ct-Scan Market Research and Analysis, 2017-2023 ($ Million)
Table 7 Global Oropharyngeal Cancer Pet-Ct Scan Market Research and Analysis, 2017-2023 ($ Million)
Table 8 Global Oropharyngeal Cancermarket Research and Analysis by Treatment Type, 2017-2023 ($ Million)
Table 9 Global Oropharyngeal Cancer Surgery Market Research and Analysis, 2017-2023 ($ Million)
Table 10 Global Oropharyngeal Cancer Chemotherapy Market Research and Analysis, 2017-2023 ($ Million)
Table 11 Global Oropharyngeal Cancer Radiation Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 12 Global Oropharyngeal Cancer Targeted Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 13 Global Others Oropharyngeal Cancer Market Research and Analysis, 2017-2023 ($ Million)
Table 14 Global Oropharyngeal Cancer Market Research and Analysis by End-Users, 2017-2023 ($ Million)
Table 15 Global Hospitals Market Research and Analysis, 2017-2023 ($ Million)
Table 16 Global Ambulatory Surgery Centres Market Research and Analysis, 2017-2023 ($ Million)
Table 17 Global Others Market Research and Analysis, 2017-2023 ($ Million)
Table 18 North American Oropharyngeal Cancer Market Research and Analysis, by Approach 2017-2023 ($ Million)
Table 19 North American Oropharyngeal Cancer Market Research and Analysis, by End User 2017-2023 ($ Million)
Table 20 North American Oropharyngeal Cancer Market Research and Analysis, by Countries 2017-2023 ($ Million)
Table 21 European Oropharyngeal Cancer Market Research and Analysis by Approach, 2017-2023 ($ Million)
Table 22 European Oropharyngeal Cancer Market Research and Analysis by End User, 2017-2023 ($ Million)
Table 23 European Oropharyngeal Cancer Market Research and Analysis by Countries, 2017-2023 ($ Million)
Table 24 Asia Pacific Oropharyngeal Cancer Market Research and Analysis by Approach, 2017-2023 ($ Million)
Table 25 Asia Pacific Oropharyngeal Cancer Market Research and Analysis by End User, 2017-2023 ($ Million)
Table 26 Asia Pacific Oropharyngeal Cancer Market Research and Analysis by Countries, 2017-2023 ($ Million)
Table 27 Rest of the World Oropharyngeal Cancer Market Research and Analysis by Approach, 2017-2023 ($ Million)
Table 28 Rest of the World Oropharyngeal Cancer Market Research and Analysis by End User, 2017-2023 ($ Million)
Table 29 Rest of the World Oropharyngeal Cancer Market Research and Analysis by Countries, 2017-2023 ($ Million)

List of Figures:
Figure 1 Global Oropharyngeal Cancer Market Share by Treatment Type, 2017 vs 2023 (%)
Figure 2 Global Oropharyngeal Cancer Market Share by End User, 2017 vs 2023 (%)
Figure 3 Global Oropharyngeal Cancer Market Share by Geography, 2017 vs 2023 (%)
Figure 4 North American Oropharyngeal Cancermarket Size, 2017-2023 ($ Million)
Figure 5 United States Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 6 Canada Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 7 European Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 8 UK Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 9 Germany Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 10 Spain Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 11 France Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 12 Italy Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 13 ROE Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 14 Asia Pacific Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 15 India Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 16 China Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 17 Japan Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 18 RoAPAC Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Figure 19 Rest of the World Oropharyngeal Cancer Market Size, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AB Sciences
  • Advaxis Inc.
  • Astrazeneca Plc
  • Bayer Ag
  • Boston Biomedical
  • Bristol-Myers Squibb CoMPany
  • GE Healthcare
  • Genticel S.A.
  • Immunovaccine, Inc.
  • Inovio Pharmaceuticals
  • Kolltan Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Novartis Ag
  • Pnp Therapeutics Inc.
  • Synta Pharmaceuticals Corp
  • Vlpbio
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll